rs13386404

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000091.5(COL4A3):​c.828+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0462 in 1,603,438 control chromosomes in the GnomAD database, including 5,152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 2264 hom., cov: 32)
Exomes 𝑓: 0.039 ( 2888 hom. )

Consequence

COL4A3
NM_000091.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.66

Publications

7 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-227254194-A-G is Benign according to our data. Variant chr2-227254194-A-G is described in ClinVar as Benign. ClinVar VariationId is 255007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A3NM_000091.5 linkc.828+20A>G intron_variant Intron 14 of 51 ENST00000396578.8 NP_000082.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A3ENST00000396578.8 linkc.828+20A>G intron_variant Intron 14 of 51 1 NM_000091.5 ENSP00000379823.3

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17979
AN:
151864
Hom.:
2249
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.326
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0552
Gnomad ASJ
AF:
0.0752
Gnomad EAS
AF:
0.0680
Gnomad SAS
AF:
0.0433
Gnomad FIN
AF:
0.0661
Gnomad MID
AF:
0.0541
Gnomad NFE
AF:
0.0290
Gnomad OTH
AF:
0.0844
GnomAD2 exomes
AF:
0.0580
AC:
14441
AN:
249070
AF XY:
0.0521
show subpopulations
Gnomad AFR exome
AF:
0.333
Gnomad AMR exome
AF:
0.0358
Gnomad ASJ exome
AF:
0.0772
Gnomad EAS exome
AF:
0.0673
Gnomad FIN exome
AF:
0.0626
Gnomad NFE exome
AF:
0.0292
Gnomad OTH exome
AF:
0.0530
GnomAD4 exome
AF:
0.0387
AC:
56114
AN:
1451462
Hom.:
2888
Cov.:
29
AF XY:
0.0376
AC XY:
27211
AN XY:
722890
show subpopulations
African (AFR)
AF:
0.331
AC:
10919
AN:
33014
American (AMR)
AF:
0.0380
AC:
1699
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0767
AC:
1996
AN:
26026
East Asian (EAS)
AF:
0.103
AC:
4090
AN:
39586
South Asian (SAS)
AF:
0.0367
AC:
3157
AN:
86050
European-Finnish (FIN)
AF:
0.0560
AC:
2991
AN:
53386
Middle Eastern (MID)
AF:
0.0708
AC:
406
AN:
5738
European-Non Finnish (NFE)
AF:
0.0251
AC:
27697
AN:
1102980
Other (OTH)
AF:
0.0527
AC:
3159
AN:
59994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2285
4570
6855
9140
11425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1246
2492
3738
4984
6230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.119
AC:
18025
AN:
151976
Hom.:
2264
Cov.:
32
AF XY:
0.118
AC XY:
8729
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.326
AC:
13503
AN:
41416
American (AMR)
AF:
0.0551
AC:
842
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0752
AC:
261
AN:
3470
East Asian (EAS)
AF:
0.0684
AC:
354
AN:
5176
South Asian (SAS)
AF:
0.0423
AC:
204
AN:
4826
European-Finnish (FIN)
AF:
0.0661
AC:
696
AN:
10526
Middle Eastern (MID)
AF:
0.0514
AC:
15
AN:
292
European-Non Finnish (NFE)
AF:
0.0290
AC:
1969
AN:
67980
Other (OTH)
AF:
0.0835
AC:
176
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
692
1384
2077
2769
3461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0782
Hom.:
348
Bravo
AF:
0.127
Asia WGS
AF:
0.0690
AC:
242
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive Alport syndrome Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.024
DANN
Benign
0.60
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13386404; hg19: chr2-228118910; COSMIC: COSV67415786; API